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announcements
University ranks first in impact
study. An international ranking of

750 universities, conducted by the
Center for Science and Technology
Studies of Leiden University in the
Netherlands, finds that Rockefeller
has the highest percentage of frequently cited science publications
worldwide, ahead of MIT, Harvard,
UC Berkeley, Stanford, Caltech and
Princeton, among others. The data,
based on publications indexed by
Thomson Reuters between 2009
and 2012, revealed that 29.1 percent of the university’s publications
were among the top ten percent
most frequently cited.
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FACULTY RECRUITMENT

CAMPUS NEWS

Structural biologist, focused on cell Drug discovery
transport machinery, to join faculty fund begins
making grants
by WYNNE PARRY

by LESLIE CHURCH

proposal to build a 160,000 square
foot laboratory building over the
FDR Drive was formally approved
by the city on May 14. The project,
which has been in development
for over two years and under city
review since last fall, was passed
unanimously. The approval paves
the way for construction to begin in
the second half of 2015.
Outdoor film series premieres. This
summer, catch a movie on Peggy
Rockefeller Plaza. The film series,
presented by Human Resources,
will feature The Intouchables on
June 19 at 8:30 p.m., The Grand
Budapest Hotel on July 17 at 8:30,
and Frozen on August 21 at 7:45.
Attendees are encouraged to bring
lawn chairs and blankets. There
will be free popcorn, and ice cream,
candy and non-alcoholic beverages
will be sold.
Take advantage of new Rockefeller
perks. The list of employee perks
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River building is approved by
NY City Council. The university’s

Jue Chen, a structural biologist whose
research focuses on transporter proteins
that act as the cell’s pumping machinery,
will join Rockefeller as professor and head
of laboratory in July. Dr. Chen, currently
a tenured professor of biology at Purdue
University in Indiana, is especially interested in the role of transporter proteins in
health and disease.
Dr. Chen and a second new faculty
member, Joseph Gleeson, are the first midcareer faculty members to be recruited to
the university since Jean-Laurent Casanova
moved his lab to Rockefeller in 2008. (Dr.

Gleeson, from the University of California, San Diego, is a geneticist interested in
childhood brain diseases; he will be profiled in the next issue of BenchMarks.)
Transporter proteins, located in the cell’s
membrane, are responsible for hauling
some molecules, such as nutrients, into the
cell, and pushing others, such as toxins, out.
To accomplish this, cells must sometimes
work against a concentration gradient,
pumping molecules from an area of lower
concentration to one of a higher concentration. Like rolling a ball uphill, this process
continued on page 2

Inaugural ‘Science Saturday’ draws families

PHOTO: SCOTT RUDD

now includes: discounted member rates at The Cliffs, a climbing
gym in Long Island City; reduced
entrance fees at Body World at
Discovery Times Square; discounts
at Slick Rock, a vacation getaway
in the White Oak Mountains of
North Carolina; discounted rent at
17 Manhattan Mini Storage locations; and a 20 percent discount
on airport parking at The Parking
Spot. See inside.rockefeller.edu/hr/
perks for details.
Announcements for this page may be
submitted to zveilleux@rockefeller.edu.
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Watch and learn. An attendee of Rockefeller’s Science Saturday event, held in May, looks on as
A. James Hudspeth, F.M. Kirby Professor and head of the Laboratory of Sensory Neuroscience,
demonstrates how nerve cells send electrical signals. Jointly hosted by the Development Office’s
Parents & Science initiative and the Science Outreach program, headed by Jeanne Garbarino,
the day-long event was open to children ages 6 to 18 and their parents, grandparents and
teachers. The festivities included more than 20 learning stations, scattered throughout the
CRC, which were conceptualized and staffed by nearly 70 Rockefeller lab heads, postdocs and
students, as well as former Summer Science Research Program participants.
Attendees were invited to observe scientific demonstrations — a cow’s eye dissection and
a microscope for exploring the skin, for example — and roll up their sleeves to take part in
experiments and activities themselves, such as watching photosynthesis in action, building brain
cells out of candy to learn how neurons communicate and extracting DNA from bananas. Staff
members led tours of the bio-imaging center and the precision fabrication facility, and Daniel
Kronauer, head of the Laboratory of Insect Social Evolution, gave the visitors an inside look at the
world of ants and insect societies. In all, 740 guests attended, about half of whom were children.
“Parents & Science has introduced nearly 3,000 new friends to Rockefeller since it was
created in 2007,” says Marc Tessier-Lavigne, the university’s president. “Science Outreach has
developed relationships with countless schools in the New York area. As we continue to enhance
our efforts to promote scientific literacy, Science Saturday will become a key program for igniting
a lifelong interest in science in the youngest generation.”

A new $25 million initiative, created earlier
this academic year to help develop basic
research discoveries into new medical
therapies, has had a promising launch, with
$1.55 million in awards granted to Rockefeller scientists in its initial phase.
The first awards are for proof-of-concept
projects aimed at identifying and validating
potential therapeutic targets. They include
pilot funding for 12 early stage projects,
two novel diagnostics, one vaccine and one
stem cell therapy approach. Funding was
also provided to four more advanced projects: one for development of a vaccine and
three for novel cancer therapeutics. In total,
20 proposals submitted by researchers in 17
Rockefeller labs received funding.
The grants are from the Robertson
Therapeutic Development Fund, established
at Rockefeller by noted investment manager
Julian Robertson and his family through
the Robertson Foundation. Mr. Robertson,
chairman and chief executive officer of Tiger Management, has been a member of the
university’s Board of Trustees since 2001.
A second round of review is now underway to consider larger clinical development
grants, which will fund drug design, toxicology testing and, in some cases, phase I
clinical trials. The open call period for early
clinical development proposals ended in
early May, and decisions will be announced
this month.
“The Robertson Fund is unique in
that it provides the necessary resources to
enable Rockefeller researchers to pursue
important studies that are rarely, if ever,
supported by conventional funding mechanisms,” says Bruce Conway, the fund’s
program director.
The fund is an important complement to the Tri-Institutional Therapeutics
Discovery Institute (TDI), a joint venture
with Memorial Sloan Kettering Cancer
Center and Weill Cornell Medical College
designed to link academic researchers with
partners in the pharmaceutical sector (see
“Tri-I drug discovery institute soon to announce first projects,” page 2).
The fund supports projects in the early
and late stages of the drug development
process that are not covered by TDI, as well
as biological products that are not part of
TDI’s current mission. In this way, the fund
will help to bridge critical gaps in drug discovery, ensuring that a range of promising
findings made in the university’s labs have
the best chance of becoming new medicines.
“Julian Robertson’s extraordinary gift is
already enabling nearly two dozen innovative projects to take an important step
forward,” says Marc Tessier-Lavigne, the
university’s president. “The funds make it
possible for our scientists to test whether
their advances are candidates to become new
medicines, and Bruce Conway’s guidance is
helping to ensure that the resources are used
efficiently to support projects that have the
greatest potential to benefit patients.”

CAMPUS NEWS

Tri-I drug discovery institute soon to announce first projects
The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI), an initiative with
Memorial Sloan Kettering Cancer Center
and Weill Cornell Medical College begun
last fall to help expedite early-stage drug
discovery, will announce this month the
first projects it has selected for funding. Six
proposals will be funded from among 48
letters of interest submitted by researchers
at the three institutions.
The independent, nonprofit institute
represents a novel partnership of academic
institutions working to turn discoveries
made in basic science labs into therapeutics. With its own scientific advisory board
and board of directors, the institute’s focus
is on the early stages of developing compounds that make possible all-important
“proof of concept” studies — those that
increase the likelihood that targeting a specific biologic pathway can favorably alter
the course of a disease.
Tri-I TDI’s collaboration with pharmaceutical and biotechnology companies will
benefit drug discovery work at all three
institutions; the first such collaboration, with
Takeda, a global research-based pharmaceutical company headquartered in Japan,
leverages the expertise of Takeda’s medicinal
chemists and pharmacologists to enhance
drug discovery and translational work as

well as educational opportunities.
Founded with a $15 million gift by
Lewis and Ali Sanders, the institute conducts its medicinal chemistry activities on
the top floor of the new, state-of-the-art
Belfer Research Building at Weill Cornell,
which opened in January. A $5 million
gift from the Howard and Abby Milstein
Foundation helped enable the creation of
the medicinal chemistry facilities.
Projects will likely reflect the diverse
interests of the member institutions’ faculty,
from addressing the developing world’s most
deadly diseases — tuberculosis and malaria
among them — to Alzheimer’s, cancer, HIV,
heart disease and obesity, to neglected or
“orphan” diseases that afflict small numbers
of people. Each scientist’s home institution
will retain its intellectual property.
“The board of directors selects research
projects based on the creativity of their
ideas and the potential they show for
developing therapies,” says Michael Foley,
the Sanders Director of Tri-I TDI, who was
hired in December. “We’ve received a number of impressive proposals and are excited
to get the funding process underway.”
Tri-I TDI plans to focus initially on
projects that involve small chemical molecules. Candidate drugs may be licensed
out to complete the later steps of drug
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by LESLIE CHURCH

Discovery center. The Tri-I Therapeutics Discovery Institute’s medicinal chemistry activities are housed on
the top floor of Weill Cornell Medical College’s new state-of-the-art Belfer Research Building.

development, such as manufacturing and
the conduct of clinical trials, or trials may
be run at the three institutions’ clinical and
translational science centers and clinical
trial offices.
“This institute will greatly enhance the
ability of basic science labs at the three
institutions to translate their discoveries
into new medicines,” says Marc Tessier-

Lavigne, the university’s president. “This
exciting collaboration will also serve as a
link between institutional researchers and
industry experts in medicinal chemistry,
compound screening and drug development. It’s a partnership that will help lower
barriers in the drug discovery process and
ultimately lead to new therapies for some
of our most difficult and deadly diseases.”

CAMPUS NEWS

IT amps up bandwidth, eases genomic data transfers
by LESLIE CHURCH
For labs on campus that sequence genomes — and share
30,000 pages of plain text — every second, or 300 users
more sequencing being done off-site at places like the New
those large data sets with other institutions — a recent
could each transfer one megabit per second. Although fine
York Genome Center. The need to get large amounts of
quadrupling in internet bandwidth means an end to the
for general internet usage such as browsing the web or
data on and off campus is greater.”
practice of slowing down uploads or scheduling them durstreaming video, this level of service could not easily acRockefeller’s bandwidth has come a long way since the
ing overnight hours. In April the university upgraded its incommodate large data transfers.
dial-up era of the 1980s, when the university’s T1 connecternet connection to two gigabits
tion offering 1.5 megabits per secper second for both incoming and
ond was considered cutting-edge.
outgoing traffic. The new higher
In 2002, average usage was just
speed is approximately 130 times
under 10 megabits per second.
faster than a typical residential
Looking forward, the universibroadband connection.
ty is poised to continue to expand
“In recent months we began
bandwidth as needed, thanks to
seeing these big transfers going on
its membership in a networkduring the day, and they had the
sharing consortium of academic
potential to slow down connecinstitutions in the state and city.
tions for the rest of campus,” says
The New York State Education
Jerry Latter, associate vice presiand Research Network (NYSERdent of IT and the university’s
Net) is a private nonprofit that
chief information officer. “We had
was founded in 1985 as a way for
One day’s data. A graph of a typical day’s internet traffic, as metered by IT’s systems, shows the ebb of flow of data during
to start asking labs if they could
New York’s academic institutions
business hours. A pronounced spike between 2 and 4 p.m. was likely a large set of data being retrieved.
perform large data transfers on
to tap into a high-speed network.
nights and weekends, or throttle their transfer speeds. We
IT, which keeps careful track of internet consumption,
NYSERNet maintains a city-wide network of “dark” fiber
weren’t completely maxing out our bandwidth, but it was
notes that usage typically peaks around lunchtime and
that links its institutional members and connects them to a
close enough that we were getting nervous about it.”
tapers off after 5 p.m. But with technologies such as high
communications hub in downtown Manhattan.
For large customers like universities, internet service
throughput sequencing, which generate data files as large
“Dark fiber means that it’s only being used by these
providers sell connections in a wide range of bandwidths.
as two terabytes, IT started seeing sharp spikes whenever
institutions, which have the option to turn it on when
In recent years the university’s connection was capable of
these files were retrieved or shared.
they need it,” says Mr. Latter. “We pay for the dark fiber
transferring 300 megabits per second, meaning one user
“The nature of the science is changing,” says Mr. Latter.
at a fixed price from NYSERNet, so we’re able to increase
could upload or download 300 megabits — equivalent to
“There is more sharing of data between institutions and
bandwidth as our needs change, at a minimal cost.”

Jue Chen (continued from page 1)
requires energy. Transporter proteins consume chemical energy to do this job.
Dr. Chen studies the structure, biochemistry and function of transporter
proteins that power themselves with
ATP, a molecule often described as the
cell’s energy currency. For this reason,
these proteins are known as ATP-binding
cassette (or ABC) transporters. Scientists
have identified about 2,000 members of
this widely studied family of proteins. Dr.
Chen has mapped in detail how the parts
of a particular ABC transporter protein,
the maltose transporter, work together to
transport sugar into the bacterium E. coli.
She made what is perhaps her most important contribution so far by revealing the
complete cycle of the maltose transporter
protein, which scientists use as a model to
study other members of the ABC family.
The maltose transporter works by

bringing a sugar, known as maltose, into
bacterial cells and converting it into ATP,
which in turn powers the transporter. Using
a technique known as X-ray crystallography, Dr. Chen and her colleagues explored
the protein’s structure down to the atomic
level and devised a way to capture the
transporter in mid-action.
“Jue’s research has thrown light onto
the operation of ubiquitous cellular machines that transport key molecules into
and out of cells, and her ongoing work
will have many important implications for
human health,” says Rockefeller president
Marc Tessier-Lavigne. “It is my pleasure to
welcome her to the Rockefeller community, where she will join a strong group of
structural biologists working to solve some
of the toughest problems in biology.”
Moving forward, Dr. Chen wants
to apply the lessons from the maltose

transporter to human disease and immune
response. The human body contains 48
different ABC transporters that participate
in all kinds of important cellular processes.
About a dozen have been linked to various
diseases, including cystic fibrosis.
One such protein, for instance, plays a
protective role in the blood-brain barrier
that protects the central nervous system.
This transporter, p-glycoprotein, turns harmful in cancerous cells. “It has turned out that
p-glycoprotein actually pumps the drugs
out of the cancer cell before they reach their
targets inside the cell,” Dr. Chen says.
She is also tackling new questions related to transporter proteins. “The move to
Rockefeller appeals to me because I know
it will give me the opportunity to establish
collaborations with colleagues, particularly
in immunology and biophysics,” she says.
Chen was born in Changsha in China’s

Hunan province. After three years at Tongji
University in Shanghai, she transferred to
Ohio University in Athens, where her uncle
was a math professor. She did her doctoral
work at Harvard University with Don C.
Wiley, a prominent structural biologist. She
went on to Baylor College of Medicine for
her postdoc, and then to Purdue.
Dr. Chen will bring a handful of students and postdocs from Purdue with her
to Rockefeller. Her lab will be located in
the Rockefeller Research Building, where a
new cluster of structural biology labs will
be grouped.
“As a scientist, you are trying to solve a
puzzle, and to go after nature’s secrets with
the hope that your work can benefit humanity in the end. To me, it is about going
after something so beautiful,” Chen says. “I
cannot believe I am paid to do what I want
to do anyway.”

AWARDS AND HONORS

Surgeon and writer Atul Gawande awarded Lewis Thomas Prize
by LESLIE CHURCH
tell us about science’s aesthetic and philoalarming accounts of medical mishaps and
profound effects on health.
sophical dimensions, providing not merely
miracles.
After earning his B.S. from Stanford
new information but cause for reflection,
Better, which was selected as one of the
University, Dr. Gawande received a master’s
even revelation.” It was named after its
10 best books of 2007 by Amazon.com,
degree in philosophy, politics and economfirst recipient, writer, educaics from Balliol College at
tor and physician-scientist
Oxford University, where
Lewis Thomas. Past recipients
he was Rhodes Scholar.
of the award include Oliver
He earned his M.D. from
Sacks, Jared Diamond and
Harvard Medical School and
E.O. Wilson. Last year’s prize
his M.P.H. from the Harvard
honored research physiologist
School of Public Health.
Frances Ashcroft, who wrote
Dr. Gawande was a senior
The Spark of Life, in which
adviser in the Department of
she explains electricity in the
Health and Human Services
body through experiences the
in the Clinton administrareader can relate to.
tion. He is executive direcDr. Gawande’s books have
tor of Ariadne Labs, a joint
all been New York Times
venture of Brigham and
bestsellers. Complications,
Women’s Hospital and
a collection of stories about
Harvard School of Public
his experiences as a surgical
Health, and is cofounder and
resident, was a finalist for
chairman of Lifebox, an inthe National Book Award
ternational not-for-profit. He
Bestselling surgeon. Gawande (left), whose books explore ways to improve pain 2002. In it, Dr. Gawande,
has received two National
tient outcomes, received the Lewis Thomas Prize, presented by Vice President for
who is also a professor of
Magazine Awards, an AcadAcademic Affairs Mike Young, at a ceremony in Caspary Auditorium in March.
surgery at Harvard Medical
emy Health’s Impact Award
School and a professor in the department
and The Checklist Manifesto, published in
and a MacArthur Fellowship, and he has
of health policy and management at the
2009, are explorations of ways to improve
been named one of the world’s hundred
Harvard School of Public Health, uses a
patient outcomes, including how a simple
most influential thinkers by Foreign Policy
disarming style to detail the sometimes
checklist in the operating room can have
and TIME.
PHOTO: SCOTT RUDD

Among the limits of modern medicine is
the element of human error. Atul Gawande,
surgeon, professor, writer and public health
researcher, reminds us that doctors make
mistakes. But as an advocate for reducing
error and increasing efficiency in health
care, he also wants to help the profession
make fewer of them.
Dr. Gawande, who practices general and
endocrine surgery at Brigham and Women’s
Hospital, was honored with the 2014
Lewis Thomas Prize for Writing about
Science at a ceremony in Rockefeller’s
Caspary Auditorium in March.
“Through his books, Dr. Gawande
achieves the ideal of the Lewis Thomas
Prize, which is to write about science in a
way that inspires others to think about it
from a new perspective,” said Mike Young,
vice president for academic affairs and
head of the Laboratory of Genetics, who
spoke at the award ceremony. “Dr. Gawande is not only changing the way we think
about best practices in medicine, but also
about the U.S. healthcare system.”
The Lewis Thomas Prize was established in 1993 by the university’s Board of
Trustees and honors “the rare individual
who bridges the worlds of science and the
humanities — whose voice and vision can

Milestones

(continued from page 4)

Michel Nussenzweig, a member of The Practitioners Society of New York, a distinguished
organization of medical doctors that was
founded in 1882. Dr. Nussenzweig, Zanvil A.
Cohn and Ralph M. Steinman Professor, is
head of the Laboratory of Molecular Immunology and a Howard Hughes Medical Institute investigator. He studies molecular aspects
of adaptive and innate immune responses.

Amanda Bermudez, teacher, Child and Fam-

Armin Lahiji, postdoctoral associate, Tarak-

hovsky Lab.

Alessandro Rosa, member of the adjunct faculty, Brivanlou Lab.

Clementine Boccon-Gibod, foreign research

Diane Lane, visiting fellow, McEwen Lab.

Anthony Sacchetti, payroll manager, Finance

Published:

Jacinta Bustamante, member of the adjunct

Jesse Ausubel, La Liberazione dell’Ambiente

Jorg Calis, postdoctoral fellow, Rosenberg Lab.

ily Center.

intern, Casanova Lab.

Kathleen Bonifacio, postdoctoral associate,

Krueger Lab.

Melanie Laurin, postdoctoral associate, Fuchs

Lab.

Eleni Bratanis, foreign research intern, Fisch-

Juan Li, postdoctoral associate, Casanova Lab.

Darnell Lab.

faculty, Casanova Lab.

Julio Cesar Cetrulo Lorenzi, postdoctoral as-

sociate, Nussenzweig Lab.

Mei Ki Chan, grants management specialist,
Sponsored Research and Program Development.
Aurelie Cobat, visiting fellow, Casanova Lab.
Bruce Conway, program director, Therapeutic

Jun Funabiki, research associate, Nurse Lab.

sanova Lab.

Tobias Bartsch, postdoctoral associate, Hud-

speth Lab.

Diane Darneau, foreign research intern, Ca-

sanova Lab.

Theresa Desmond, special assistant, Chief of

Staff.

Brian Dill, research support specialist, Pro-

teomics Resource Center.

Dorit Farfara, postdoctoral associate, Gleeson

Lab.

chl Lab.

Sandra Garcet, research associate, Krueger

Lab.

Max Luedemann, foreign research intern,

Alice Stanton, research assistant, Tessier-

Tuschl Lab.

Lavigne Lab.

Maryem Manzoor, research assistant, Pfaff

Sarah Stern, visiting fellow, Friedman Lab.

Lab.

Shay Stern, postdoctoral fellow, Bargmann Lab.

Christian Mayer, postdoctoral associate, Nus-

Tomohisa Sujino, postdoctoral fellow, Mucida
Raissa Tanqueco, research assistant, Tavazoie

Lab.

Kiley McKinstrie, human resources generalist,

Emmanuelle Thinon, postdoctoral associate,

Lucian Medrihan, research associate, Green-

Karen Tumaneng, postdoctoral associate,

Fabio Melo, visiting fellow, Allis Lab.

Hasan Vatandaslar, foreign research intern,

Human Resources.

gard Lab.

Aaron Mertz, postdoctoral associate, Fuchs

Lab.

Eleftherios Michailidis, postdoctoral associ-

ate, Rice Lab.

Katrina Millard, clinical research nurse, Hos-

pital Nursing Inpatient.

Rand Miller, postdoctoral associate, Kapoor

Lab.

Assia Mouri, foreign research intern, Green-

Hang Lab.

Fuchs Lab.

Tuschl Lab.

Jimmy Weidmann, visiting student, McEwen

Lab.

Jonathan Whicher, postdoctoral associate,

MacKinnon Lab.

Xianfang Wu, postdoctoral associate, Rice

Lab.

Xiao-Lun Wu, visiting professor, Libchaber Lab.
Meg Younger, postdoctoral associate, Voss-

Alan Gerber, postdoctoral fellow, Roeder Lab.

gard Lab.

hall Lab.

Beatrice Goilav, visiting assistant professor,

Awni Mousa, bioinformatics specialist, Heintz

Romy Zemel, visiting assistant professor, Rice

Riva Gottesman, manager of health information systems, Hospital HIS.

Kian-Hong Ng, postdoctoral fellow, Chua Lab.

Susan Zolla-Pazner, member of the adjunct

Juan Grau, member of the adjunct faculty,

Leonora Olivos Cisneros, research assistant,

Tuschl Lab.

Coller Lab.

Antoine Gruet, research specialist, Klinge Lab.
Beverley Guthrie-Turenne, lab helper, Media

and Glassware Resource Center.

David Hoytema van Konijnenburg, visiting

student, Mucida Lab.

Kuangfu Hsiao, postdoctoral associate, Heintz

Lab.

Julien Hsieh, instructor in clinical investiga-

Lab.

Shinji Noda, research associate, Krueger Lab.

Kronauer Lab.

Francesca Ortenzio, visiting medical student,

Krueger Lab.

Christopher Park, visiting fellow, R. Darnell

Lab.

Michael Pearce, lab manager, Rice Lab.
Capucine Picard, member of the adjunct fac-

ulty, Casanova Lab.

Lauren Pietila, research assistant, Brivanlou

tive Bioscience Center.

David Kaback, visiting professor, Rout Lab.

Sivan Ben Avraham Shulman, study coordi-

Joo Yong Kim, visiting student, Chua Lab.

Zorine Ramcharan, accountant, Finance Con-

trollers Office.

Sandra Kurz, foreign research intern, Rice Lab.

Noe Ramirez Alejo, foreign research intern,

Tobias Bengtsson, visiting student, Coller Lab.

Lab.

dents Club.

Anne Puel, member of the adjunct faculty,

nator, Nussenzweig Lab.

ulty, Rice Lab.

Megan Sribour, research specialist, Fuchs Lab.

Lab.

Shawn Belton, animal attendant, Compara-

Brady Lab.

Robert Schwartz, member of the adjunct fac-

Sylvia Lipford, animal technician, Heintz Lab.

Richard Hutt, clinical research coordinator,

Serkan Belkaya, postdoctoral associate, Casa-

Jessica Schneider, postdoctoral associate,

Orli Sela, assistant, Nottebohm Lab.

tion, Vosshall Lab.

nova Lab.

Kirsty Sawicka, postdoctoral associate, R.

Lab.

Jackie McHugh, manager, Faculty and Stu-

Knight Lab.

Luciano Marraffini, in Cell’s “40 Under 40,” a
collection of profiles recognizing accomplished
young researchers shaping current and future
trends in science. The profiles will be featured
throughout 2014 in print and online issues,
as well as on the web at cell.com/40/under40.
Dr. Marraffini is head of the Laboratory of
Bacteriology and investigates the exchange of
genetic material among bacteria.

Alexander Antipenko, research specialist, Ca-

Greengard Lab.

Sophia Lindkvist, visiting student, McEwen

Marshall Crumiller, postdoctoral associate,

Featured:

sistant, Comparative Bioscience Center.

Thomas Liebmann, postdoctoral associate,

senzweig Lab.

Fabian Fechner, foreign research intern, Tus-

Natalie Alejandro, cage card compliance as-

Juncheng Li, research assistant, Heintz Lab.

Development Fund.

Maxwell Dalmasi, receiving clerk, Purchasing.

John Aitchison, visiting professor, Rout Lab.

Controllers Office.

Ilaria Sani, postdoctoral associate, Freiwald

Lab.

An interview with Sebastian White in How
We Found the Higgs Boson, a book by Michael Krause published by Rich & Famous
Publishing Berlin. Dr. White, a senior research
associate in Mitchell Feigenbaum’s Laboratory of Mathemetical Physics, describes his
role as a project manager for the Zero Degree
Calorimeter experiment in the framework of
the ATLAS collaboration at CERN.

Hired:

nova Lab.

Elia Bove, research associate, Ruta Lab.

etti Lab.

(The Liberation of the Environment), an autobiography published in April by the Italian
publisher Di Renzo. It is part of a series of
such books on people with interesting careers.
The book spans Mr. Ausubel’s roots, childhood and education, as well as the major
chapters of his career: climate change, industrial ecology, Census of Marine Life, DNA
barcoding, Encyclopedia of Life and Deep
Carbon Observatory. Mr. Ausubel is director
of the Program for the Human Environment.

Theo Lasseau, foreign research intern, Casa-

Hospital Program Direction.

Lab.

faculty, Nussenzweig Lab.

Promoted (academic appointments):
Judilyn Fuentes-Duculan, to senior research

associate, Krueger Lab.

Florian Klein, to assistant professor of clinical

investigation, Nussenzweig Lab.

Kunihiro Uryu, to research assistant professor,
Office of Academic Affairs.
Kimihisa Yoshida, to senior research associate,

Blobel Lab.

Casanova Lab.

Casanova Lab.

This publication lists new hires, awards and
promotions. Staff promotions are listed yearly;
academic promotions and appointments are
listed monthly.

Milestones
PROMOTIONS, AWARDS AND PERSONNEL NEWS

Awarded:
C. David Allis, the 2014 Japan Prize in Life
Sciences from the Japan Prize Foundation,
for his pioneering work in epigenetics and
his discovery that chemical modifications of
DNA-packaging proteins play a key role in
regulating the activity of individual genes.
The prize, worth approximately half a million dollars, is among the most prestigious
international prizes in science. Dr. Allis is
Joy and Jack Fishman Professor and head of
the Laboratory of Chromatin Biology and
Epigenetics.

Kayo Inaba, the L’Oréal-UNESCO Women in
Science award, which supports eminent women
throughout the world who are working in the
life and physical sciences. Dr. Inaba, known for
her work on dendritic cells, is being honored as
the Asia-Pacific recipient. Dr. Inaba is an adjunct faculty member in Michel Nussenzweig’s
Laboratory of Molecular Immunology at
Rockefeller, and previously worked with Ralph
Steinman. She is also a professor in the Graduate School of Biostudies at Kyoto University in
Japan, as well as the vice president for gender
equality and the director of the Center for
Women Researchers at Kyoto.

Jesse Ausubel, the 2014 Paradigm Prize from

Sebastian Klinge, a Career Development

the Breakthrough Institute, a Californiabased think tank focused on ecological issues. Mr. Ausubel, director of the Program
for the Human Environment, was chosen
for his research and writings on population,
technology, energy, materials, agriculture and
pollution — work that has implications for
reducing humankind’s negative impacts on
the nonhuman world.

Jean-Laurent Casanova, the Presidential

Award from the Clinical Immunology Society.
Dr. Casanova researches the genetic basis of
pediatric infectious diseases and is head of
the St. Giles Laboratory of Human Genetics
of Infectious Diseases and a Howard Hughes
Medical Institute investigator.

Jean-Laurent Casanova, the Norman J. Siegel

New Member Outstanding Science Award,
from the American Pediatric Society, for his
discoveries of single-gene lesions in children
that confer selective vulnerability to certain
infectious illnesses.

Brian Chait and Michael Rout, an award

from the Jain Foundation, which aims to
find cures for muscular dystrophies caused
by dysferlin protein deficiency. Dr. Chait,
Camille and Henry Dreyfus Professor and
head of the Laboratory of Mass Spectrometry
and Gaseous Ion Chemistry, specializes in the
development and use of mass spectrometry as
a tool for investigating a variety of biological
and biochemical phenomena. Dr. Rout, head
of the Laboratory of Cellular and Structural
Biology, uses biochemical, biophysical and
structural approaches to characterize macromolecular assemblies, with an emphasis on
the nuclear pore complex.

Barry Coller, the Karl Landsteiner Memorial
Award and Lectureship, from the American
Association of Blood Banks. The award honors Karl Landsteiner, a former Rockefeller
professor whose research laid the foundation for modern blood transfusion therapy.
Dr. Coller is recognized for his dedication
to improving patient and donor care and
safety within transfusion medicine and cellular therapy. He is physician in chief, David
Rockefeller Professor and head of the Allen
and Frances Adler Laboratory of Blood and
Vascular Biology.
Titia de Lange, the Canada Gairdner International Award, given for significant discoveries
in medical science. The Gairdner is Canada’s
highest scientific award and is considered
among the most prestigious international
prizes in science. Dr. de Lange, who is Leon
Hess Professor and head of the Laboratory of
Cell Biology and Genetics, is one of six recipients of the award this year, and will receive
approximately $90,000.
Elaine Fuchs, the 2014 Pezcoller Foundation-

AACR International Award for Cancer
Research from the American Association for
Cancer Research, for her contributions to the
understanding of skin, skin stem cells and
skin-related disease. The award recognizes an
individual scientist of international renown
who has made a major scientific discovery
in basic or translational cancer research. Dr.
Fuchs is Rebecca C. Lancefield Professor, head
of the Laboratory of Mammalian Cell Biology and Development and a Howard Hughes
Medical Institute investigator.

David D. Ho, the 2013 Prince Mahidol Award
in Medicine, from the Kingdom of Thailand.
The award, which comes with a medal and
a $100,000 prize, is given for outstanding
achievements in medicine. Dr. Ho pursues the
development of drugs and vaccines to prevent HIV transmission. He is Irene Diamond
Professor and scientific director and chief
executive officer of the Aaron Diamond AIDS
Research Center.

Award from the Human Frontier Science Program for his work on the early events of eukaryotic ribosome assembly. The award provides $300,000 over three years to establish
each researcher’s first independent laboratory.
Dr. Klinge, one of 12 recipients, joined Rockefeller in August. He is head of the Laboratory
of Protein and Nucleic Acid Chemistry.

Sebastian Klinge, a Sloan Research Fellow-

ship from the Alfred P. Sloan Foundation. The
fellowship supports early-career scientists
who have demonstrated special creative ability in science, technology, engineering, mathematics and economics. The grant is $50,000
over a two-year period to support Dr. Klinge’s
research on the structure and function of ribosomes, the cell’s protein factories.

Mary Jeanne Kreek, the Lifetime Service

Award from the NIH’s National Institute on
Drug Abuse, in recognition of outstanding
contribution to the field of drug addiction
research. Dr. Kreek, Patrick E. and Beatrice
M. Haggerty Professor and head of the Laboratory of the Biology of Addictive Diseases,
is the inaugural winner of this award, which
was presented in May.

Gaby Maimon, a Presidential Early Career
Award for Scientists and Engineers, the highest
honor bestowed by the U.S. government to scientists and engineers in the early stages of their
careers. Dr. Maimon, head of the Laboratory of
Integrative Brain Function, was one of 20 NIHfunded scientists chosen to receive this recognition, and was honored by President Obama at
a White House ceremony on April 14.
Nora Pencheva, a Harold M. Weintraub
Graduate Student Award, one of the country’s
most prestigious graduate student prizes. The
award is given by the Fred Hutchinson Cancer
Research Center and recognizes outstanding
achievement during graduate studies in the
biological sciences. Ms. Pencheva, a graduate
fellow in Sohail Tavazoie’s Laboratory of Systems Cancer Biology, was one of 13 recipients
from across North America. She studies the
molecular biology of metastatic melanoma —
the most deadly type of skin cancer.
Thomas P. Sakmar, the Invitation Fellow

Award from the Japan Society for the Promotion of Science. The award supports a
one-month visit to Japan where Dr. Sakmar
will give scientific lectures at several Japanese
universities and research centers. Dr. Sakmar,
Richard M. and Isabel P. Furlaud Professor
and head of the Laboratory of Chemical
Biology and Signal Transduction, conducts
biological and chemical investigations of G
protein coupled receptors.

Daniel Schramek, the 2nd Annual Regeneron

Prize for Creative Innovation, from Regeneron
Pharmaceuticals, Inc. Applicants submit a
“dream” project in biomedical research, and
the awardees — one graduate student and
one postdoc — receive a $50,000 prize and a
$5,000 donation to support seminars at their
home institutions. Dr. Schramek’s proposal used
the idea of sequence-based personalized medicine to tackle the most devastating features of
cancer such as metastasis and drug resistance.
He is a postdoc in Elaine Fuchs’s Laboratory of
Mammalian Cell Biology and Development.

Agata Smogorzewska, an inaugural Pershing
Square Sohn Prize for Young Investigators in
Cancer Research from the Pershing Square
Sohn Cancer Research Alliance, for her proposal on the role of genome instability in
driving tumor formation. The prize, which
includes $200,000 per year for up to three
years, provides funding to New York scientists with innovative ideas in cancer research
and is meant to bridge the gap between academic science and the business community.
Dr. Smogorzewska is head of the Laboratory
of Genome Maintenance.

OBITUARY

Nobel laureate and longtime faculty
member Gerald Edelman dies at 84
by LESLIE CHURCH
Gerald M. Edelman, a Rockefeller
alumnus, former faculty member and
Nobel laureate who uncovered the
chemical structure of the antibody in
1961, died on May 18 at the age of 84.
A graduate of Henry Kunkel’s
laboratory and a member of the university’s second graduating class, Dr.
Edelman received his Ph.D. in 1960
and remained at
Rockefeller for
34 years, becoming Vincent Astor
Professor. He
also served as assistant and then
associate dean of
graduate studies.
He left the
university in
1992 to become
director of The
Neurosciences
Institute in San
Diego and
president of the
institute’s publicly supported
nonprofit parent
organization, the
Neurosciences
Research Foundation. He was also
professor and chairman of the department of neurobiology at The Scripps
Research Institute.
“Dr. Edelman left an indelible mark
on the university,” says Marc TessierLavigne, the university’s president. “He
sparked scientific progress in numerous
fields — biophysics, protein chemistry,
immunology, cell biology and neurobiology. Just as importantly, he also
helped shape Rockefeller’s graduate
program and served as a mentor to
dozens of young scientists.”
Dr. Edelman was born in New York
City on July 1, 1929. At first embarking on a career as a professional
violinist, he changed course to pursue
science, earning a bachelor’s degree at
Ursinus College in 1950 and his M.D.
at the University of Pennsylvania in
1954. He spent a year at the Johnson
Foundation of Medical Physics, and,
after a medical house officership at the
Massachusetts General Hospital, he
served as a captain in the Army Medi-

Marc Tessier-Lavigne, the Burke Award

from Burke Rehabilitation Hospital in White
Plains, given for significant contributions to
the field of rehabilitation. Dr. Tessier-Lavigne,
president of the university, Carson Family
Professor and head of the Laboratory of
Brain Development and Repair, is one of four
recipients who will be honored at a ceremony
in June.

Named:
Shruti Naik and Alexey A. Soshnev, Damon

Runyon Cancer Research Foundation fellows.
The nonprofit organization, which supports
innovative early-career researchers, grants this
three-year award to outstanding postdoctoral
scientists conducting basic and translational
cancer research in the laboratories of leading
senior investigators across the country. Each
received more than $150,000 to work on innovative projects. Dr. Naik is a member of
Elaine Fuchs’s Laboratory of Mammalian Cell
Biology and Development and Dr. Soshnev is
a member of C. David Allis’s Laboratory of
Chromatin Biology and Epigenetics.

cal Corps attached to the American
Hospital in Neuilly-sur-Seine, France.
Dr. Edelman began his research
career with an interest in the immune
system. By severing the sulphide bonds
that hold together immunoglobulin G,
he showed that this antibody was made
of more than 1,300 amino acids in four
chains. It’s these chains that create a
pocket capable
of capturing an
antigen, which
triggers an immune response.
These studies led
to his receiving
the 1972 Nobel
Prize in Physiology or Medicine,
which he shared
with Rodney
R. Porter. As
a result of Dr.
Edelman’s work,
mammalian
antibodies were
classified and
harnessed for use
in the diagnosis
of infectious
diseases.
Turning his attention to developmental processes in the 1970s, Dr.
Edelman made important discoveries
on cell adhesion molecules and their
roles in the development of an animal’s
shape as well as its nervous system. He
then focused on neurobiology, specifically brain function and human consciousness, and in recent years became
a leading figure in the emerging field of
synthetic neural modeling.
Dr. Edelman was one of three
alumni to be presented with an honorary degree at the university’s 2008
convocation, which recognized the
graduate program’s 50th anniversary.
He used his speech to convey the importance of one particular component
of the scientific endeavor: “Science is
imagination in the service of verifiable
truth. … And in fact, there are some
times when imagination leads to a
world change.”
Dr. Edelman is survived by his wife,
Maxine Morrison, sons Eric and David
and daughter Judith.

Thomas Tuschl, a finalist for the European

Inventor Award 2014, the first European prize
to distinguish inventors who have made an
outstanding contribution to innovation, economy and society. Dr. Tuschl is a finalist for his
work on an RNA interference method in human cells. The final winners of the award will
be announced in Berlin in June. Dr. Tuschl is
head of the Laboratory of RNA Molecular
Biology and a Howard Hughes Medical Institute investigator.

Elected:
Robert B. Darnell, a member of the National
Academy of Sciences. Dr. Darnell is one of 84
new members, elected for their distinguished
and continuing achievements in original research. Dr. Darnell studies a group of rare brain
diseases, the paraneoplastic neurologic disorders, and how they arise in conjunction with
immune responses to cancer. He is Robert and
Harriet Heilbrunn Professor, head of the Laboratory of Molecular Neuro-oncology and a
Howard Hughes Medical Institute investigator.
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